involv
central
nervou
system
cn
consid
typic
manifest
dengu
report
indic
may
occur
mani
case
could
conjectur
incid
might
higher
fatal
case
dengu
possibl
address
dengu
epidem
northeastern
brazilian
state
endem
dengu
type
colleagu
determin
incid
cn
involv
viru
postmortem
examin
subject
die
suspect
infecti
diseas
knowledg
dengu
viru
may
invad
cn
also
lead
question
role
play
patient
present
symptom
sign
cn
infect
separ
studi
colleagu
address
issu
retrospect
examin
incid
dengu
infect
patient
suspect
viral
mening
meningoenceph
endem
region
brazil
possibl
period
epidem
activ
studi
csf
live
patient
deceas
subject
use
diagnost
test
studi
found
evid
cn
involv
dengu
viru
individu
live
patient
deceas
subject
thu
least
brazil
dengu
viru
infrequ
etiolog
patient
suspect
mening
meningoenceph
patient
die
infect
due
viru
howev
approxim
half
evid
cn
invas
recommend
durat
therapi
latent
tuberculosi
daili
rifampin
alon
month
weekli
observ
isoniazid
inh
rifapentin
month
daili
inh
alon
month
requirememt
prolong
durat
inh
administr
administ
singl
agent
believ
result
inact
nonrepl
bacilli
addit
inh
activ
hypox
condit
exist
caseat
granuloma
metronidazol
hand
though
activ
aerob
environ
bactericid
activ
vitro
nonrepl
mycobacterium
tuberculosi
hypox
condit
vitro
lin
colleagu
examin
efficaci
metronidazol
administr
cynomolg
monkey
model
latent
tuberculosi
infect
could
activ
administr
antitumor
necrosi
factor
antibodi
model
administr
inh
alon
month
inh
plu
rifampin
month
highli
effect
prevent
reactiv
diseas
administr
metronidazol
alon
month
equal
effect
metronidazol
also
demonstr
benefit
activ
tuberculosi
ad
inh
rifampin
administ
month
potenti
role
metronidazol
treatment
multidrugresist
tuberculosi
current
examin
trial
south
korea
patient
random
receiv
placebo
addit
standard
secondlin
regimen
l
wong
aust
c
et
al
viral
find
adult
hematolog
patient
neutropenia
plo
one
standard
approach
neutropen
patient
present
fever
perform
care
clinic
microbiolog
evalu
immedi
initi
empir
broadspectrum
antibiot
therapi
presenc
infect
howev
document
approxim
role
virus
less
well
defin
exclud
allogen
hematopoiet
stem
cell
recipi
colleagu
stockholm
prospect
studi
adult
fever
neutropenia
well
neutropen
patient
afebril
nasopharyng
np
aspir
examin
polymeras
chain
reaction
test
presenc
broad
rang
common
respiratori
virus
blood
screen
virus
commonli
identifi
site
immunocompromis
patient
viral
pathogen
detect
subject
np
aspir
blood
sampl
posit
fever
diagnosi
chronic
lymphocyt
leukemia
significantli
overrepres
among
detect
viru
viru
detect
np
aspir
upper
respiratori
symptom
symptom
present
neg
np
sampl
viral
pathogen
detect
np
aspir
febril
patient
afebril
patient
rhinoviru
infect
respiratori
virus
detect
fever
includ
rhinoviru
n
respiratori
syncyti
viru
n
adenoviru
n
influenza
n
metapneumoviru
n
patient
posit
blood
sampl
bk
viru
detect
cytomegaloviru
parvoviru
epsteinbarr
viru
adenoviru
viru
detect
number
individu
instanc
viral
load
copiesml
except
follow
patient
fever
patient
cytomegaloviru
copiesml
bk
viru
copiesml
parvoviru
copiesml
among
patient
febril
neutropenia
document
bacteri
infect
concomit
viral
infect
found
view
opposit
direct
least
viral
pathogen
detect
patient
febril
neutropenia
total
also
document
bacteri
infect
separ
recent
studi
children
febril
neutropenia
use
luminex
xtag
multiplex
reversetranscript
polymeras
chain
reaction
amplifi
nucleic
acid
respiratori
secret
found
evid
viral
respiratori
infect
frequent
detect
rhinovirusenteroviru
follow
small
number
influenza
parainfluenza
coronaviru
metapneumoviru
neither
adenoviru
rsv
detect
respiratori
symptom
present
episod
febril
neutropenia
viru
posit
p
without
fever
associ
viral
nucleic
acid
detect
analysi
provid
evid
presenc
known
common
pathogen
virus
patient
febril
neutropenia
subject
requir
explor
applic
sensit
method
requir
use
virusspecif
primer
variou
new
gener
deep
sequenc
techniqu
may
soon
provid
real
surpris
